The University of Texas MD Anderson Cancer Center is a comprehensive cancer center in Houston, Texas. It is the largest cancer center in the U.S. and one of the original three comprehensive cancer centers in the country.

During the past decade, Md Anderson Can Cnt conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Md Anderson Can Cnt" #1 collaborator was "University of Pennsylvania" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Md Anderson Can Cnt" are "Acute Myeloid Leukemia" (2 trials), "Melanoma" (2 trials), "Breast Cancer" (1 trials), "Diffuse Large B-cell Lymphoma (DLBCL)" (1 trials) and "Follicular Lymphoma" (1 trials). Many other conditions were trialed in "Md Anderson Can Cnt" in a lesser frequency.

Most popular intervention types in "Md Anderson Can Cnt" are "Biological" (5 trials), "Drug" (5 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "BMS-982470 (recombinant interleukin-21)" (1 trials), "BMS-986213" (1 trials), "Decitabine and Cedazuridine (ASTX727)" (1 trials), "Everolimus" (1 trials) and "Everolimus Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Md Anderson Can Cnt" are 8 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Md Anderson Can Cnt". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Md Anderson Can Cnt, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Md Anderson Can Cnt, 4 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".